DISCOUNT-ZERTIFIKAT - APOS PHAR Stock

DE000DJ4MN13

Delayed Deutsche Boerse AG 13:35:16 2024-07-05 EDT
3.75 ^EUR	+0.54%

3 months	+3.04%
6 months	+18.04%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart APONTIS PHARMA AG

Latest news about APONTIS PHARMA AG

APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the strategic development of the Company	06-27	EQ
Apontis Pharma AG Appoints Thomas Zimmermann to the Management Board, Effective 1 July 2024	06-27	CI
APONTIS PHARMA continues to gear organization towards growth and internationalization – Renowned industry expert leads supply chain management	06-04	EQ
DD: APONTIS PHARMA AG: Thomas Milz, buy	05-14	EQ

More news

Quotes 5-day view

Date	Price	Change
24-07-05	3.75	+0.54%
24-07-04	3.73	0.00%
24-07-03	3.73	0.00%
24-07-02	3.73	0.00%
24-07-01	3.73	0.00%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 01:35 pm

More quotes

Static data

Product type	Discount-Zertifikate
Buy / Sell	CALL
Underlying	APONTIS PHARMA AG
Issuer	DZ BANK
WKN	DJ4MN1
ISIN	DE000DJ4MN13
Date issued	2023-08-04
Maturity	2025-06-20 (350 Days)
Parity	1 : 1
Emission price	3.48 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	3.78 €
Lowest since issue	2.56 €
Spread	0.12 €
Spread %	3.10%

Company Profile

Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

Sector

More about the company

Ratings for Apontis Pharma AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Apontis Pharma AG

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

8.46 EUR

Average target price

17.38 EUR

Spread / Average Target

+105.38%

Consensus